Search Results for "Wockhardt Europe Ltd"

02:23 EST 3rd March 2015 | BioPortfolio

Matching Channels

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Amyloidosis

AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Allegra Generic Shapes Wockhardt U.S. Private Label OTC Entry

Wockhardt USA has made 60mg and 180mg fexofenadine products available for retailers. While other firms already provide generic equivalent formulations of Allegra Allergy, Wockhardt’s products also a...

Wockhardt Shapes Its Entry Into Private Label OTCs With Allegra Allergy Generic

Wockhardt USA has 60mg and 180mg fexofenandine products available for retailers. While other firms already provide generic equivalent formulations of Allegra Allergy, Wockhardt’s products also are e...

Rebound Making Wockhardt An Acquisition Target?

Despite its problems with the U.S. FDA, Wockhardt appears to have rebounded to the extent that it may have made itself a possible acquisition target, including by its fellow Indian drug maker, Lupin.

Wockhardt Again Recalls Blood Pressure Drug In U.S.

For the third time in four months, Wockhardt has recalled its metoprolol generic of AstraZeneca's Toprol for treating high blood pressure, again for failing dissolution tests.

India's Wockhardt says FDA raises new concerns about Waluj plant

MUMBAI (Reuters) - Shares in Wockhardt Ltd fell as much as 5.3 percent on Thursday after the Indian drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant already...

India's Wockhardt Q2 profit plunges on U.S. export bans

MUMBAI, Nov 3 (Reuters) - Indian generic drugmaker Wockhardt Ltd reported a 97 percent drop in quarterly net profit, as regulatory bans on the company's manufacturing plants in India due to poor produ...

MHRA: Wockhardt non-compliance includes all APIs for EU market

Following Wockhardt’s decision to cease supplying APIs to the EU market, the UK drug regulator MHRA (Medicines and Healthcare Products Regulatory Agency) has updated its statement of noncompliance t...

Wockhardt Drug Gets India's First U.S. QIDP Fast-Track Status

Wockhardt has become the first India drug maker to receive U.S. FDA Qualified Infectious Disease Product status, a fast-track review designation, for two versions of its anti-MRSA drug.

Matching PubMed Articles

Treatment and care of TB across Europe.

There continues to be profound differences in TB incidences as well as in TB treatment and care across Europe in recent years. High TB incidences are observed in Eastern Europe and especially among in...

Maritime route of colonization of Europe.

The Neolithic populations, which colonized Europe approximately 9,000 y ago, presumably migrated from Near East to Anatolia and from there to Central Europe through Thrace and the Balkans. An alternat...

Inequality in the long run.

This Review presents basic facts regarding the long-run evolution of income and wealth inequality in Europe and the United States. Income and wealth inequality was very high a century ago, particularl...

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America.

Introduction: Rates of both TB/HIV co-infection and multi-drug-resistant (MDR) TB are increasing in Eastern Europe (EE). Data on the clinical management of TB/HIV co-infected patients are scarce. Our ...

A survey of the European Venous Forum on education and training in venous surgery and phlebology in Europe.

Venous training in Europe is lacking a formal curriculum among various specialties related to management of venous diseases. We conducted a survey in order to have a snapshot on the actual education a...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement